Frequently Asked Questions

A person who willfully and knowingly fails to report the dispensing of a controlled substance as required by this law commits a misdemeanor of the first degree, punishable as provided in s. 775.082 or s. 775.083, F.S. Further, the department shall issue a non-disciplinary citation to any prescriber or dispenser who fails to consult the system as required by this subsection for an initial offense. Each subsequent offense is subject to disciplinary action pursuant to s. 456.073, F.S.

The Department has published a notice of rule development and will be amending Rule 64K-1.002, FAC . The PDMP will continue to accept submissions in the ASAP 2009 version 4.2 and the new 4.2a standard for one year from the effective date of the rule.

Dispensers are required to submit controlled-substance dispensing data to E-FORCSE through the PMP Clearinghouse using the ASAP 4.2B format

According to Florida Statute § 893.055(3)(a), Florida Statutes (2025), a dispenser must report to E-FORCSE for each Schedule II–V controlled substance dispensed. The required information includes:

• The prescribing practitioner’s name, DEA registration number, NPI or other identifier, and prescription date.
• The date the prescription was filled and method of payment.
• The patient’s full name, address, telephone number, and date of birth.
• The controlled substance name, NDC, quantity, and strength.
• The dispensing pharmacy or practitioner’s identifying information, including name, DEA number, Florida license/permit number, address, and NPI as applicable.
• Whether it was an initial prescription or refill and the number of refills ordered.
• The name of the individual picking up the prescription and the type and issuer of identification provided.
• Other appropriate identifying information required by Department of Health rule.

Yes, there are four exemptions from reporting:

Controlled substances administered to patients in a facility;

• Controlled substances dispensed in the health care system of the Department of Corrections; and
• Controlled substances dispensed to patients under the age of 16 are exempt from reporting to E-FORCSE.
• Hospice

Under Florida Statute § 893.055 (2025), the Florida Prescription Drug Monitoring Program (E-FORCSE) requires reporting of controlled substances in:

• Schedule II
• Schedule III
• Schedule IV
• Schedule V

Dispensers are required to report to the PDMP each time a controlled substance is dispensed to a patient, as soon thereafter as possible, but no later than close of business the day after the prescription is dispensed unless an extension or exemption is approved by the Department of Health.

A dispensing practitioner is a practitioner authorized by law to prescribe drugs who may dispense such drugs to her or his patients in the regular course of her or his practice in compliance with s. 465.0276, F.S. Dispensing practitioners may include: physicians, dentists, certified optometrists, podiatrists, advanced practice registered nurses and physician assistants.

A dispenser is a dispensing health care practitioner, pharmacy, or pharmacist licensed to dispense controlled substances to the ultimate consumer or his or her agent in or into this state.

A dispenser must consult the PDMP on the new prescription and on each subsequent refill.

§ 893.055(8) A prescriber or dispenser or a designee of a prescriber or dispenser must consult the system to review a patient’s controlled substance dispensing history before prescribing or dispensing a controlled substance for a patient age 16 or older. This requirement does not apply when prescribing or dispensing a nonopioid controlled substance listed in Schedule V of s. 893.03 or 21 U.S.C. 812 or prescribing or dispensing a controlled substance to a patient who has been admitted to hospice pursuant to s. 400.6095. For purposes of this subsection, a “nonopioid controlled substance” is a controlled substance that does not contain any amount of a substance listed as an opioid in s. 893.03 or 21 U.S.C. 812.

Answer: § 893.055(8) A prescriber or dispenser or a designee of a prescriber or dispenser must consult the system to review a patient’s controlled substance dispensing history before prescribing or dispensing a controlled substance for a patient age 16 or older. This requirement does not apply when prescribing or dispensing a nonopioid controlled substance listed in Schedule V of s. 893.03 or 21 U.S.C. 812 or prescribing or dispensing a controlled substance to a patient who has been admitted to hospice pursuant to s. 400.6095. For purposes of this subsection, a “nonopioid controlled substance” is a controlled substance that does not contain any amount of a substance listed as an opioid in s. 893.03 or 21 U.S.C. 812.

The duty to consult the system does not apply when the system:

• Is determined by the department to be nonoperational; or
• Cannot be accessed by the dispenser or a designee of the dispenser because of a temporary technological or electrical failure